Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort study
Clinical trials with immune checkpoint inhibitors (ICI) in adrenocortical carcinoma (ACC) have yielded contradictory results. We aimed to evaluate treatment response and safety of ICI in ACC in a real-life setting.Retrospective cohort study of 54 patients with advanced ACC receiving ICI as compassio...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 2023
|
| In: |
European journal of endocrinology
Year: 2023, Jahrgang: 188, Heft: 6, Pages: 485-493 |
| ISSN: | 1479-683X |
| DOI: | 10.1093/ejendo/lvad054 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/ejendo/lvad054
|
| Verfasserangaben: | Hanna Remde, Laura Schmidt-Pennington, Miriam Reuter, Laura-Sophie Landwehr, Marie Jensen, Harald Lahner, Otilia Kimpel, Barbara Altieri, Katharina Laubner, Jochen Schreiner, Joerg Bojunga, Stefan Kircher, Catarina Alisa Kunze, Anne Pohrt, Maria-Veronica Teleanu, Daniel Hübschmann, Albrecht Stenzinger, Hanno Glimm, Stefan Fröhling, Martin Fassnacht, Knut Mai, and Matthias Kroiss |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1853779326 | ||
| 003 | DE-627 | ||
| 005 | 20240307064817.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230727s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ejendo/lvad054 |2 doi | |
| 035 | |a (DE-627)1853779326 | ||
| 035 | |a (DE-599)KXP1853779326 | ||
| 035 | |a (OCoLC)1425214240 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Remde, Hanna |e VerfasserIn |0 (DE-588)1193061466 |0 (DE-627)1671595696 |4 aut | |
| 245 | 1 | 0 | |a Outcome of immunotherapy in adrenocortical carcinoma |b a retrospective cohort study |c Hanna Remde, Laura Schmidt-Pennington, Miriam Reuter, Laura-Sophie Landwehr, Marie Jensen, Harald Lahner, Otilia Kimpel, Barbara Altieri, Katharina Laubner, Jochen Schreiner, Joerg Bojunga, Stefan Kircher, Catarina Alisa Kunze, Anne Pohrt, Maria-Veronica Teleanu, Daniel Hübschmann, Albrecht Stenzinger, Hanno Glimm, Stefan Fröhling, Martin Fassnacht, Knut Mai, and Matthias Kroiss |
| 264 | 1 | |c June 2023 | |
| 300 | |b Illustrationen | ||
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Veröffentlicht: 01. Juni 2023 | ||
| 500 | |a Gesehen am 27.07.2023 | ||
| 520 | |a Clinical trials with immune checkpoint inhibitors (ICI) in adrenocortical carcinoma (ACC) have yielded contradictory results. We aimed to evaluate treatment response and safety of ICI in ACC in a real-life setting.Retrospective cohort study of 54 patients with advanced ACC receiving ICI as compassionate use at 6 German reference centres between 2016 and 2022.Objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS), overall survival (OS), and treatment-related adverse events (TRAE) were assessed.In 52 patients surviving at least 4 weeks after initiation of ICI, ORR was 13.5% (6-26) and DCR was 24% (16-41). PFS was 3.0 months (95% CI, 2.3-3.7). In all patients, median OS was 10.4 months (3.8-17). 17 TRAE occurred in 15 patients, which was associated with a longer PFS of 5.5 (1.9-9.2) vs 2.5 (2.0-3.0) months (HR 0.29, 95% CI, 0.13-0.66, P = 0.001) and OS of 28.2 (9.5-46.8) vs 7.0 (4.1-10.2) months (HR 0.34, 95% CI, 0.12-0.93). Positive tissue staining for programmed cell death ligand 1 (PD-L1) was associated with a longer PFS of 3.2 (2.6-3.8) vs 2.3 (1.6-3.0, P < 0.05) months. Adjusted for concomitant mitotane use, treatment with nivolumab was associated with lower risk of progression (HR 0.36, 0.15-0.90) and death (HR 0.20, 0.06-0.72) compared to pembrolizumab.In the real-life setting, we observe a response comparable to other second-line therapies and an acceptable safety profile in ACC patients receiving different ICI. The relevance of PD-L1 as a marker of response and the potentially more favourable outcome in nivolumab-treated patients require confirmation. | ||
| 700 | 1 | |a Schmidt-Pennington, Laura |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reuter, Miriam |e VerfasserIn |4 aut | |
| 700 | 1 | |a Landwehr, Laura-Sophie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jensen, Marie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lahner, Harald |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kimpel, Otilia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Altieri, Barbara |e VerfasserIn |4 aut | |
| 700 | 1 | |a Laubner, Katharina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schreiner, Jochen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bojunga, Joerg |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kircher, Stefan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kunze, Catarina Alisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pohrt, Anne |e VerfasserIn |4 aut | |
| 700 | 1 | |a Teleanu, Maria-Veronica |d 1977- |e VerfasserIn |0 (DE-588)1136788557 |0 (DE-627)893574074 |0 (DE-576)49028566X |4 aut | |
| 700 | 1 | |a Hübschmann, Daniel |d 1981- |e VerfasserIn |0 (DE-588)1099133653 |0 (DE-627)858143798 |0 (DE-576)469237082 |4 aut | |
| 700 | 1 | |a Stenzinger, Albrecht |e VerfasserIn |0 (DE-588)139606106 |0 (DE-627)703395238 |0 (DE-576)312432755 |4 aut | |
| 700 | 1 | |a Glimm, Hanno |d 1967- |e VerfasserIn |0 (DE-588)113880677 |0 (DE-627)51985120X |0 (DE-576)289777879 |4 aut | |
| 700 | 1 | |a Fröhling, Stefan |d 1969- |e VerfasserIn |0 (DE-588)120890046 |0 (DE-627)080950302 |0 (DE-576)188733930 |4 aut | |
| 700 | 1 | |a Fassnacht, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mai, Knut |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kroiss, Matthias |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of endocrinology |d Oxford : Oxford University Press, 1994 |g 188(2023), 6 vom: Juni, Seite 485-493 |h Online-Ressource |w (DE-627)30151741X |w (DE-600)1485160-X |w (DE-576)079421466 |x 1479-683X |7 nnas |a Outcome of immunotherapy in adrenocortical carcinoma a retrospective cohort study |
| 773 | 1 | 8 | |g volume:188 |g year:2023 |g number:6 |g month:06 |g pages:485-493 |g extent:9 |a Outcome of immunotherapy in adrenocortical carcinoma a retrospective cohort study |
| 856 | 4 | 0 | |u https://doi.org/10.1093/ejendo/lvad054 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230727 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 120890046 |a Fröhling, Stefan |m 120890046:Fröhling, Stefan |d 50000 |e 50000PF120890046 |k 0/50000/ |p 19 | ||
| 998 | |g 113880677 |a Glimm, Hanno |m 113880677:Glimm, Hanno |d 50000 |e 50000PG113880677 |k 0/50000/ |p 18 | ||
| 998 | |g 139606106 |a Stenzinger, Albrecht |m 139606106:Stenzinger, Albrecht |d 910000 |d 912000 |e 910000PS139606106 |e 912000PS139606106 |k 0/910000/ |k 1/910000/912000/ |p 17 | ||
| 998 | |g 1099133653 |a Hübschmann, Daniel |m 1099133653:Hübschmann, Daniel |d 50000 |e 50000PH1099133653 |k 0/50000/ |p 16 | ||
| 998 | |g 1136788557 |a Teleanu, Maria-Veronica |m 1136788557:Teleanu, Maria-Veronica |d 910000 |d 910100 |e 910000PT1136788557 |e 910100PT1136788557 |k 0/910000/ |k 1/910000/910100/ |p 15 | ||
| 999 | |a KXP-PPN1853779326 |e 4358178464 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Veröffentlicht: 01. Juni 2023","Gesehen am 27.07.2023"],"person":[{"given":"Hanna","display":"Remde, Hanna","role":"aut","family":"Remde"},{"role":"aut","family":"Schmidt-Pennington","display":"Schmidt-Pennington, Laura","given":"Laura"},{"display":"Reuter, Miriam","given":"Miriam","role":"aut","family":"Reuter"},{"role":"aut","family":"Landwehr","given":"Laura-Sophie","display":"Landwehr, Laura-Sophie"},{"given":"Marie","display":"Jensen, Marie","role":"aut","family":"Jensen"},{"role":"aut","family":"Lahner","given":"Harald","display":"Lahner, Harald"},{"given":"Otilia","display":"Kimpel, Otilia","family":"Kimpel","role":"aut"},{"given":"Barbara","display":"Altieri, Barbara","family":"Altieri","role":"aut"},{"given":"Katharina","display":"Laubner, Katharina","family":"Laubner","role":"aut"},{"role":"aut","family":"Schreiner","given":"Jochen","display":"Schreiner, Jochen"},{"role":"aut","family":"Bojunga","display":"Bojunga, Joerg","given":"Joerg"},{"display":"Kircher, Stefan","given":"Stefan","role":"aut","family":"Kircher"},{"given":"Catarina Alisa","display":"Kunze, Catarina Alisa","role":"aut","family":"Kunze"},{"display":"Pohrt, Anne","given":"Anne","role":"aut","family":"Pohrt"},{"family":"Teleanu","role":"aut","display":"Teleanu, Maria-Veronica","given":"Maria-Veronica"},{"display":"Hübschmann, Daniel","given":"Daniel","family":"Hübschmann","role":"aut"},{"given":"Albrecht","display":"Stenzinger, Albrecht","family":"Stenzinger","role":"aut"},{"given":"Hanno","display":"Glimm, Hanno","role":"aut","family":"Glimm"},{"role":"aut","family":"Fröhling","given":"Stefan","display":"Fröhling, Stefan"},{"given":"Martin","display":"Fassnacht, Martin","family":"Fassnacht","role":"aut"},{"display":"Mai, Knut","given":"Knut","role":"aut","family":"Mai"},{"given":"Matthias","display":"Kroiss, Matthias","role":"aut","family":"Kroiss"}],"recId":"1853779326","name":{"displayForm":["Hanna Remde, Laura Schmidt-Pennington, Miriam Reuter, Laura-Sophie Landwehr, Marie Jensen, Harald Lahner, Otilia Kimpel, Barbara Altieri, Katharina Laubner, Jochen Schreiner, Joerg Bojunga, Stefan Kircher, Catarina Alisa Kunze, Anne Pohrt, Maria-Veronica Teleanu, Daniel Hübschmann, Albrecht Stenzinger, Hanno Glimm, Stefan Fröhling, Martin Fassnacht, Knut Mai, and Matthias Kroiss"]},"language":["eng"],"origin":[{"dateIssuedDisp":"June 2023","dateIssuedKey":"2023"}],"relHost":[{"pubHistory":["Volume 130, issue 1 (Jan 1994)-"],"note":["Gesehen am 21.08.25"],"language":["eng"],"part":{"issue":"6","pages":"485-493","extent":"9","text":"188(2023), 6 vom: Juni, Seite 485-493","year":"2023","volume":"188"},"titleAlt":[{"title":"EJE"},{"title":"European journal of endocrinology"},{"title":"official journal of the European Federation of Endocrine Societies"},{"title":"EJE"}],"disp":"Outcome of immunotherapy in adrenocortical carcinoma a retrospective cohort studyEuropean journal of endocrinology","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"30151741X","origin":[{"publisherPlace":"Oxford ; Bristol","dateIssuedKey":"1994","dateIssuedDisp":"1994-","publisher":"Oxford University Press ; BioScientifica Ltd."}],"title":[{"title_sort":"European journal of endocrinology","subtitle":"EJE : clinical and translational endocrinology from around the globe","title":"European journal of endocrinology"}],"id":{"zdb":["1485160-X"],"issn":["1479-683X"],"eki":["30151741X"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"9 S.","noteIll":"Illustrationen"}],"id":{"eki":["1853779326"],"doi":["10.1093/ejendo/lvad054"]},"title":[{"subtitle":"a retrospective cohort study","title":"Outcome of immunotherapy in adrenocortical carcinoma","title_sort":"Outcome of immunotherapy in adrenocortical carcinoma"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a REMDEHANNAOUTCOMEOFI2023 | ||